Time trends, improvements and national auditing of rectal cancer management over an 18-year period

Colorectal Disease

Volumn 17, Issue 9, 2015, Pages O168-O179

  Kodeda, K ^a   Johansson, R ^b   Zar, N ^c   Birgisson, H ^d   Dahlberg, M ^b   Skullman, S ^e   Lindmark, G ^f   Glimelius, B ^d   Pahlman L ^d   Martling, A ^g  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c RYHOV COUNTY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e SKARABORG HOSPITAL   (Sweden)

^f HELSINGBORG HOSPITAL   (Sweden)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Quality control; Rectal neoplasms; Registries; Surgery; Therapy

Indexed keywords

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHEMORADIOTHERAPY; COHORT ANALYSIS; COLOSTOMY; DISEASE FREE SURVIVAL; EXTERNAL VALIDITY; FEMALE; HARTMANN PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MIDDLE AGED; MULTIVISCERAL RESECTION; NATIONAL AUDITING; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PATIENT SELECTION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM ANTERIOR RESECTION; RECTUM CANCER; RECTUM CARCINOMA; RECURRENCE RISK; RELATIVE SURVIVAL; REOPERATION; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TOTAL QUALITY MANAGEMENT; TREND STUDY; VERY ELDERLY; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT RADIOTHERAPY; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOADJUVANT THERAPY; PALLIATIVE THERAPY; POSTOPERATIVE COMPLICATIONS; RECTAL NEOPLASMS; STOMA; SWEDEN; TRENDS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; CHEMORADIOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; NEOADJUVANT THERAPY; OSTOMY; PALLIATIVE CARE; PATIENT CARE TEAM; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SURVIVAL RATE; SWEDEN;

EID: 84938797083     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.13060     Document Type: Article

References (35)

1. Edwards DP, Sexton R, Heald RJ, Moran BJ. Long-term results show triple stapling facilitates safe low colorectal and coloanal anastomosis and is associated with low rates of local recurrence after anterior resection for rectal cancer. Tech Coloproctol 2007; 11: 17-21.
2. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 1982; 69: 613-6.
3. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.
4. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-60.
5. Glimelius B. Multidisciplinary treatment of patients with rectal cancer: development during the past decades and plans for the future. Ups J Med Sci 2012; 117: 225-36.
6. Daniels IR, Fisher SE, Heald RJ, Moran BJ. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence. Colorectal Dis 2007; 9: 290-301.
7. Taylor FG, Quirke P, Heald RJ et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter. European study. Ann Surg 2011; 253: 711-9.
8. Quirke P, Palmer T, Hutchins GG, West NP. Histopathological work-up of resection specimens, local excisions and biopsies in colorectal cancer. Dig Dis 2012; 30(Suppl 2): 2-8.
9. Engelen SM, Maas M, Lahaye MJ et al. Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge. Eur J Cancer 2013; 49: 2311-20.
10. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000; 356: 93-6.
11. Pahlman L, Bohe M, Cedermark B et al. The Swedish Rectal Cancer Registry. Br J Surg 2007; 94: 1285-92.
12. Kodeda K, Nathanaelsson L, Jung B et al. Population-based data from the Swedish Colon Cancer Registry. Br J Surg 2013; 100: 1100-7.
13. Jorgren F, Johansson R, Damber L, Lindmark G. Validity of the Swedish Rectal Cancer Registry for patients treated with major abdominal surgery between 1995 and 1997. Acta Oncol 2013; 52: 1707-14.
14. von Elm E, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-7.
15. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. N Engl J Med 1997; 336: 309-15.
16. Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Comput Programs Biomed 1985; 19: 197-207.
17. Anwar S, Peter MB, Dent J, Scott NA. Palliative excisional surgery for primary colorectal cancer in patients with incurable metastatic disease. Is there a survival benefit? A systematic review. Colorectal Dis 2012; 14: 920-30.
18. Eisenberger A, Whelan RL, Neugut AI. Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review. Int J Colorectal Dis 2008; 23: 559-68.
19. Scheer MG, Sloots CE, van der Wilt GJ, Ruers TJ. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 2008; 19: 1829-35.
20. Stillwell AP, Buettner PG, Ho YH. Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg 2010; 34: 797-807.
21. Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier AM. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol 2005; 16: 756-61.
22. Larkin JO, O'Connell PR. Multivisceral resection for T4 or recurrent colorectal cancer. Dig Dis 2012; 30(Suppl 2): 96-101.
23. Mohan HM, Evans MD, Larkin JO, Beynon J, Winter DC. Multivisceral resection in colorectal cancer: a systematic review. Ann Surg Oncol 2013; 20: 2929-36.
24. Holm T, Ljung A, Haggmark T, Jurell G, Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 2007; 94: 232-8.
25. West NP, Finan PJ, Anderin C, Lindholm J, Holm T, Quirke P. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 2008; 26: 3517-22.
26. Ortiz H, Wibe A, Ciga MA et al. Impact of a multidisciplinary team training programme on rectal cancer outcomes in Spain. Colorectal Dis 2013; 15: 544-51.
27. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Late adverse effects of radiation therapy for rectal cancer - a systematic overview. Acta Oncol 2007; 46: 504-16.
28. Gerard JP, Conroy T, Bonnetain F et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620-5.
29. Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-23.
30. Braendengen M, Tveit KM, Berglund A et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008; 26: 3687-94.
31. Nilsson PJ, van Etten B, Hospers GA, et al. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer - the RAPIDO trial. BMC Cancer 2013; 13: 279.
32. Henneman D, Snijders HS, Fiocco M et al. Hospital variation in failure to rescue after colorectal cancer surgery: results of the Dutch Surgical Colorectal Audit. Ann Surg Oncol 2013; 20: 2117-23.
33. Henneman D, van Leersum NJ, Ten Berge M et al. Failure-to-rescue after colorectal cancer surgery and the association with three structural hospital factors. Ann Surg Oncol 2013; 20: 3370-6.
34. Burke JP, Coffey JC, Boyle E, Keane F, McNamara DA. Early outcomes for rectal cancer surgery in the Republic of Ireland following a national centralization program. Ann Surg Oncol 2013; 20: 3414-21.
35. Damhuis RA, Wijnhoven BP, Plaisier PW, Kirkels WJ, Kranse R, van Lanschot JJ. Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types. Br J Surg 2012; 99: 1149-54.